Skip to content

Avanos Medical AVNS Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
Medtronic logo
MedtronicMDT
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
AMN Healthcare logo
AMN HealthcareAMN
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
Enovis logo
EnovisENOV

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's common stock, shares, outstanding?
Avanos Medical (AVNS) reported common stock, shares, outstanding of $46.67M in Q1 2026.
How has Avanos Medical's common stock, shares, outstanding changed year-over-year?
Avanos Medical's common stock, shares, outstanding increased by 0.9% year-over-year, from $46.24M to $46.67M.
What is the long-term trend for Avanos Medical's common stock, shares, outstanding?
Over 5 years (2020 to 2025), Avanos Medical's common stock, shares, outstanding has grown at a -0.6% compound annual growth rate (CAGR), from $47.92M to $46.46M.